Symbol
| APAF1
| contributors: mct/npt/pgu - updated : 05-06-2015
|
HGNC name
| apoptotic peptidase activating factor 1
|
HGNC id
| 576
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
associated with tumour progression and adverse prognosis in colorectal cancer | tumoral
|  
|  
| --over
|  
|
is related to an undifferentiated state in the testicular germ cell tumor pathway | constitutional
|  
|  
|  
| loss of function
|
results in an accumulation of neural progenitor cells (NPCs) in the developing central nervous system and thus, in perinatal lethality | constitutional
|  
|  
| --low
|  
|
APAF1-deficient cells are less prone to developing aggregates than are wild-type cells, thereby supporting the involvement of APAF1 in a mammalian model of polyQ-related diseases | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | huntington chorea | |
minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting APAF1 |
| | | |
| murine Apaf1 null die at E16.5 day with craniofacial malformation, brain overgrowth, lens and retina alteration but persistence of interdigital webs and reduced apoptosis in fibroblasts | |
a Drosophila model of Huntington disease shows that inactivation of the dark gene (Drosophila Apaf-1 related killer) suppresses the formation of polyQ aggregates and diminishes the associated pathogenesis |